National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

RevM10 gene
RevM10 is a dominant-negative mutant of HIV-1 Rev gene, which encodes a RNA-binding protein involving in nuclear trafficking of unspliced viral mRNAs. Due to the fact that Rev is essential for HIV-1 replication makes it an attractive target for antiviral approaches. Based on the notion of intracellular immunization, in vitro studies that introducing RevM10 gene into stem cells have demonstrated its ability to combat HIV-1 infection in human hematopoietic cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)




Previous:retrovector encoding mutant anti-cyclin G1, Retrovir, Revia, Revival, Revlimid
Next:REXIN-G, rexinoid NRX194204, Rezulin, RFT5-dgA immunotoxin, rhEndostatin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov